Search research articles
Contact Us
Filters
Showing results (71-80 of 135) with videos related to
Page
of 14
Sort By:
Genomics Data
|
November 23, 2016
Transcriptional profiles of WNV neurovirulence in a genetically diverse Collaborative Cross population
Richard Green, Courtney Wilkins, Sunil Thomas, et al.
Mbio
|
March 9, 2017
A Reverse Genetics Platform That Spans the Zika Virus Family Tree
Douglas G Widman, Ellen Young, Boyd L Yount, et al.
Journal of Medicinal Chemistry
|
May 12, 2025
Species-Dependent Metabolism of a Covalent nsP2 Protease Inhibitor with In Vivo Antialphaviral Activity
Mohammad Anwar Hossain, Abigail K Mayo, Anirban Ghoshal, et al.
Plos Neglected Tropical Diseases
|
April 1, 2021
Non-replicating adenovirus based Mayaro virus vaccine elicits protective immune responses and cross protects against other alphaviruses
John M Powers, Nicole N Haese, Michael Denton, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2024
Structure Activity of β-Amidomethyl Vinyl Sulfones as Covalent Inhibitors of <i>Chikungunya</i> nsP2 Cysteine Protease with Anti-alphavirus Activity
Anirban Ghoshal, Kesatebrhan Haile Asressu, Mohammad Anwar Hossain, et al.
Mbio
|
November 16, 2017
Disruption of the Opal Stop Codon Attenuates Chikungunya Virus-Induced Arthritis and Pathology
Jennifer E Jones, Kristin M Long, Alan C Whitmore, et al.
Cell Reports. Medicine
|
May 21, 2025
Chikungunya virus-specific CD4<sup>+</sup> T cells are associated with chronic chikungunya viral arthritic disease in humans
Rimjhim Agarwal, James Chang, Fernanda H Côrtes, et al.
Biorxiv : the Preprint Server for Biology
|
January 27, 2025
Species Dependent Metabolism of a Covalent nsP2 Protease Inhibitor with <i>in Vivo</i> Anti-alphaviral Activity
Mohammad Anwar Hossain, Abigail K Mayo, Anirban Ghoshal, et al.
Plos Neglected Tropical Diseases
|
March 17, 2025
Development of a virulent O'nyong'nyong challenge model to determine heterologous protection mediated by a hydrogen peroxide-inactivated chikungunya virus vaccine
Whitney C Weber, Zachary J Streblow, Takeshi F Andoh, et al.
Plos Pathogens
|
May 3, 2013
Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus
Pankaj Pal, Kimberly A Dowd, James D Brien, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 135) with videos related to
Sort By:
Page
of 14
Genomics Data
|
November 23, 2016
Transcriptional profiles of WNV neurovirulence in a genetically diverse Collaborative Cross population
Richard Green, Courtney Wilkins, Sunil Thomas, et al.
Mbio
|
March 9, 2017
A Reverse Genetics Platform That Spans the Zika Virus Family Tree
Douglas G Widman, Ellen Young, Boyd L Yount, et al.
Journal of Medicinal Chemistry
|
May 12, 2025
Species-Dependent Metabolism of a Covalent nsP2 Protease Inhibitor with In Vivo Antialphaviral Activity
Mohammad Anwar Hossain, Abigail K Mayo, Anirban Ghoshal, et al.
Plos Neglected Tropical Diseases
|
April 1, 2021
Non-replicating adenovirus based Mayaro virus vaccine elicits protective immune responses and cross protects against other alphaviruses
John M Powers, Nicole N Haese, Michael Denton, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2024
Structure Activity of β-Amidomethyl Vinyl Sulfones as Covalent Inhibitors of <i>Chikungunya</i> nsP2 Cysteine Protease with Anti-alphavirus Activity
Anirban Ghoshal, Kesatebrhan Haile Asressu, Mohammad Anwar Hossain, et al.
Mbio
|
November 16, 2017
Disruption of the Opal Stop Codon Attenuates Chikungunya Virus-Induced Arthritis and Pathology
Jennifer E Jones, Kristin M Long, Alan C Whitmore, et al.
Cell Reports. Medicine
|
May 21, 2025
Chikungunya virus-specific CD4<sup>+</sup> T cells are associated with chronic chikungunya viral arthritic disease in humans
Rimjhim Agarwal, James Chang, Fernanda H Côrtes, et al.
Biorxiv : the Preprint Server for Biology
|
January 27, 2025
Species Dependent Metabolism of a Covalent nsP2 Protease Inhibitor with <i>in Vivo</i> Anti-alphaviral Activity
Mohammad Anwar Hossain, Abigail K Mayo, Anirban Ghoshal, et al.
Plos Neglected Tropical Diseases
|
March 17, 2025
Development of a virulent O'nyong'nyong challenge model to determine heterologous protection mediated by a hydrogen peroxide-inactivated chikungunya virus vaccine
Whitney C Weber, Zachary J Streblow, Takeshi F Andoh, et al.
Plos Pathogens
|
May 3, 2013
Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus
Pankaj Pal, Kimberly A Dowd, James D Brien, et al.
Page
of 14